High-dose 5-fluorouracil infusional therapy is associated with hyperammonaemia, lactic acidosis and encephalopathy.

por Yeh, K. H., Cheng, A. L.
Publicado 1997

Lack of efficacy of troglitazone at clinically achievable concentrations, with or without 9-cis retinoic acid or cytotoxic agents, for hepatocellular carcinoma cell lines

por Shen, Y-C, Hsu, C, Chen, J-Y, Cheng, A-L
Publicado 2004

Prolonged and enhanced suppression of thymidylate synthase by weekly 24-h infusion of high-dose 5-fluorouracil

por Yeh, K-H, Yeh, S-H, Hsu, C-H, Wang, T-M, Ma, I-F, Cheng, A-L
Publicado 2000

Prognosis of advanced hepatocellular carcinoma patients enrolled in clinical trials can be classified by current staging systems

por Shao, Y-Y, Lu, L-C, Lin, Z-Z, Hsu, C, Shen, Y-C, Hsu, C-H, Cheng, A-L
Publicado 2012

Activating oxidative phosphorylation by a pyruvate dehydrogenase kinase inhibitor overcomes sorafenib resistance of hepatocellular carcinoma

por Shen, Y-C, Ou, D-L, Hsu, C, Lin, K-L, Chang, C-Y, Lin, C-Y, Liu, S-H, Cheng, A-L
Publicado 2013

Mcl-1-dependent activation of Beclin 1 mediates autophagic cell death induced by sorafenib and SC-59 in hepatocellular carcinoma cells

por Tai, W-T, Shiau, C-W, Chen, H-L, Liu, C-Y, Lin, C-S, Cheng, A-L, Chen, P-J, Chen, K-F
Publicado 2013

Helicobacter pylori sensitizes TNF-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis in human gastric epithelial cells through regulation of FLIP

por Lin, W-C, Tsai, H-F, Liao, H-J, Tang, C-H, Wu, Y-Y, Hsu, P-I, Cheng, A-L, Hsu, P-N
Publicado 2014

Efficacy and tolerability of bevacizumab plus capecitabine as first-line therapy in patients with advanced hepatocellular carcinoma

por Hsu, C-H, Yang, T-S, Hsu, C, Toh, H C, Epstein, R J, Hsiao, L-T, Chen, P-J, Lin, Z-Z, Chao, T-Y, Cheng, A-L
Publicado 2010

An open, multi-centre, phase II clinical trial to evaluate the efficacy and safety of paclitaxel, UFT, and leucovorin in patients with advanced gastric cancer

por Chao, Y, Li, C P, Chao, T Y, Su, W C, Hsieh, R K, Wu, M F, Yeh, K H, Kao, W Y, Chen, L T, Cheng, A L
Publicado 2006

Phase II study of weekly vinorelbine and 24-h infusion of high-dose 5-fluorouracil plus leucovorin as first-line treatment of advanced breast cancer

por Yeh, K H, Lu, Y S, Hsu, C H, Lin, J F, Chao, H J, Huang, T C, Chung, C Y, Chang, C S, Yang, C H, Cheng, A L
Publicado 2005

Helicobacter pylori-related diffuse large B-cell lymphoma of the stomach: a distinct entity with lower aggressiveness and higher chemosensitivity

por Kuo, S-H, Yeh, K-H, Chen, L-T, Lin, C-W, Hsu, P-N, Hsu, C, Wu, M-S, Tzeng, Y-S, Tsai, H-J, Wang, H-P, Cheng, A-L
Publicado 2014

Weekly gemcitabine plus 24-h infusion of high-dose 5-fluorouracil/leucovorin for locally advanced or metastatic carcinoma of the biliary tract

por Hsu, C, Shen, Y-C, Yang, C-H, Yeh, K-H, Lu, Y-S, Hsu, C-H, Liu, H-T, Li, C-C, Chen, J-S, Wu, C-Y, Cheng, A-L
Publicado 2004

Detection of the Helicobacter pylori CagA protein in gastric mucosa-associated lymphoid tissue lymphoma cells: clinical and biological significance

por Kuo, S-H, Chen, L-T, Lin, C-W, Wu, M-S, Hsu, P-N, Tsai, H-J, Chu, C-Y, Tzeng, Y-S, Wang, H-P, Yeh, K-H, Cheng, A-L
Publicado 2013

Phase I study of nanoliposomal irinotecan (PEP02) in advanced solid tumor patients

por Chang, T. C., Shiah, H. S., Yang, C. H., Yeh, K. H., Cheng, A. L., Shen, B. N., Wang, Y. W., Yeh, C. G., Chiang, N. J., Chang, J. Y., Chen, L. T.
Publicado 2015

Genetic polymorphisms and tissue expression of interleukin-22 associated with risk and therapeutic response of gastric mucosa-associated lymphoid tissue lymphoma

por Liao, F, Hsu, Y-C, Kuo, S-H, Yang, Y-C, Chen, J-P, Hsu, P-N, Lin, C-W, Chen, L-T, Cheng, A-L, Fann, C S J, Lin, J-T, Wu, M-S
Publicado 2014

Phase II study of weekly oxaliplatin and 24-h infusion of high-dose 5-fluorouracil and folinic acid in the treatment of advanced gastric cancer

por Chao, Y, Yeh, K H, Chang, C J, Chen, L T, Chao, T Y, Wu, M F, Chang, C S, Chang, J Y, Chung, C Y, Kao, W Y, Hsieh, R K, Cheng, A L
Publicado 2004

A phase I study of two dosing schedules of volasertib (BI 6727), an intravenous polo-like kinase inhibitor, in patients with advanced solid malignancies

por Lin, C-C, Su, W-C, Yen, C-J, Hsu, C-H, Su, W-P, Yeh, K-H, Lu, Y-S, Cheng, A-L, Huang, D C-L, Fritsch, H, Voss, F, Taube, T, Yang, J C-H
Publicado 2014

Gemcitabine and cisplatin in a multimodality treatment for locally advanced non-small cell lung cancer

por Yang, C H, Tsai, C M, Wang, L S, Lee, Y C, Chang, C J, Lui, L T, Yen, S H, Hsu, C, Cheng, A L, Liu, M Y, Chiang, S C, Chen, Y M, Luh, K T, Huang, M H, Yang, P-C, Perng, R-P
Publicado 2002

Updated results from GEST study: a randomized, three-arm phase III study for advanced pancreatic cancer

por Okusaka, Takuji, Miyakawa, H., Fujii, H., Nakamori, S., Satoh, T., Hamamoto, Y., Ito, T., Maguchi, H., Matsumoto, S., Ueno, H., Ioka, T., Boku, N., Egawa, S., Hatori, T., Furuse, J., Mizumoto, K., Ohkawa, S., Yamaguchi, T., Yamao, K., Funakoshi, A., Chen, J. S., Cheng, A. L., Sato, A., Ohashi, Y., Tanaka, M.
Publicado 2017